✦ LIBER ✦

Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa

✍ Scribed by O. Torres-Bugarı&#x0301;n; A. Ventura-Aguilar; A. Zamora-Perez; B.C. Gómez-Meda; M.L. Ramos-Ibarra; G. Morgan-Villela; A. Gutiérrez-Franco; G. Zúñiga-González

Book ID: 117767177
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 93 KB
Volume: 539
Category: Article
ISSN: 1383-5718
DOI: 10.1016/s1383-5718(03)00163-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of cisplatin + 5-FU

Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa

✍ O. Torres-Bugarín; A. Ventura-Aguilar; A. Zamora-Perez; B.C. Gómez-Meda; M.L. Ra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Corrigendum to "Evaluation of cisplation

Corrigendum to "Evaluation of cisplation + 5-FU, carboplatin +5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalitities in the buccal mucosa"

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 35 KB

8517 Phase I results from an open-label,

8517 Phase I results from an open-label, randomized, controlled, phase I/II study (ADVANTAGE) to evaluate the combination of different cilengitide regimens with cisplatin, 5-FU, and cetuximab in patients with recurrent/metastatic squamous cell cancer of the head and neck (SCCHN)

✍ Brümmendorf, T.; Guigay, J.; Mesía, R.; Trigo, J.; Keilholz, U.; Dittrich, C.; K 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 72 KB